These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3516548)

  • 41. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea.
    O'Connor D; Hynes P; Cormican M; Collins E; Corbett-Feeney G; Cassidy M
    J Clin Microbiol; 2001 Aug; 39(8):2846-9. PubMed ID: 11474001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Six years evaluation of Clostridium difficile associated diarrhea].
    Ercis S; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2004; 38(1-2):45-50. PubMed ID: 15293901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea.
    Kelly MT; Champagne SG; Sherlock CH; Noble MA; Freeman HJ; Smith JA
    J Clin Microbiol; 1987 Jul; 25(7):1244-7. PubMed ID: 3611316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clostridium difficile PCR Cycle Threshold Predicts Free Toxin.
    Senchyna F; Gaur RL; Gombar S; Truong CY; Schroeder LF; Banaei N
    J Clin Microbiol; 2017 Sep; 55(9):2651-2660. PubMed ID: 28615471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discontinuous counterimmunoelectrophoresis in the diagnosis of antibiotic-associated colitis.
    Fisher JF; Tedesco FJ; Johnson DH; Rissing JP; Walker CA; Trincher RC; Howard L; Buxton T; Agel JF
    J Clin Gastroenterol; 1982 Jun; 4(3):253-6. PubMed ID: 7096958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens.
    Alcalá L; Sánchez-Cambronero L; Catalán MP; Sánchez-Somolinos M; Peláez MT; Marín M; Bouza E
    J Clin Microbiol; 2008 Nov; 46(11):3833-5. PubMed ID: 18784313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of CIE for the detection of Clostridium difficile toxin in stool filtrates: laboratory and clinical correlation.
    Kurzynski TA; Cembrowski GS; Kimball JL
    Am J Clin Pathol; 1983 Mar; 79(3):370-4. PubMed ID: 6829506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.
    George WL; Rolfe RD; Finegold SM
    J Clin Microbiol; 1982 Jun; 15(6):1049-53. PubMed ID: 7107838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection.
    Kawada M; Annaka M; Kato H; Shibasaki S; Hikosaka K; Mizuno H; Masuda Y; Inamatsu T
    J Infect Chemother; 2011 Dec; 17(6):807-11. PubMed ID: 21725661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clostridium difficile toxin and faecal lactoferrin assays in adult patients.
    Vaishnavi C; Bhasin D; Kochhar R; Singh K
    Microbes Infect; 2000 Dec; 2(15):1827-30. PubMed ID: 11165926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of Clostridium difficile toxins A (enterotoxin) and B (cytotoxin) in clinical specimens. Evaluation of a latex agglutination test.
    Peterson LR; Holter JJ; Shanholtzer CJ; Garrett CR; Gerding DN
    Am J Clin Pathol; 1986 Aug; 86(2):208-11. PubMed ID: 3739972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occurrence of toxin-producing Clostridium difficile in antibiotic-associated diarrhea in Sweden.
    Aronsson B; Möllby R; Nord CE
    Med Microbiol Immunol; 1981; 170(1):27-35. PubMed ID: 7300801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental studies of antibiotic associated colitis.
    Bartlett JG
    Scand J Infect Dis Suppl; 1980; (Suppl 22):11-5. PubMed ID: 6937944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens.
    Laughon BE; Viscidi RP; Gdovin SL; Yolken RH; Bartlett JG
    J Infect Dis; 1984 May; 149(5):781-8. PubMed ID: 6101243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of bacterial isolation, cytotoxicity assay, and counterimmunoelectrophoresis for the detection of Clostridium difficile and its toxin.
    Jarvis W; Nunez-Montiel O; Thompson F; Dowell V; Towns M; Morris G; Hill E
    J Infect Dis; 1983 Apr; 147(4):778. PubMed ID: 6842010
    [No Abstract]   [Full Text] [Related]  

  • 56. Importance of culture for detection of Clostridium difficile toxin from stool samples to report true incidence and mortality related to C. difficile in hospitals.
    Bayardelle P
    Clin Infect Dis; 2009 Oct; 49(7):1134-5; author reply 1135. PubMed ID: 19739961
    [No Abstract]   [Full Text] [Related]  

  • 57. Detection of Clostridium difficile toxin by enzyme immunoassay, tissue culture test and culture.
    Liesenfeld O; Saeger F; Hahn H
    Infection; 1994; 22(1):29-32. PubMed ID: 8181838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Nested Polymerase Chain Reaction and Immunoassay for Rapid Diagnosis of Clostridium difficile in Children with Community Acquired Diarrhea.
    Elewa A; Sayed-Zaki ME
    Clin Lab; 2017 Feb; 63(2):321-326. PubMed ID: 28182338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis and diagnosis of clostridium difficile enterocolitis.
    Möllby R; Aronsson B; Nord CE
    Scand J Infect Dis Suppl; 1985; 46():47-56. PubMed ID: 3906856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
    Shin BM; Lee EJ; Kuak EY; Yoo SJ
    Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.